Quality Target definition

Quality Target means a Candidate Target (a) that was identified by or on behalf of Exelixis pursuant to work under the Mode of Action Program; (b) [*] Candidate Target [*] BMS Compound [*] such Candidate Target; [*] mammalian orthologue.
Sample 1Sample 2Sample 3
Quality Target means a [ * ] (a) that was identified by or on behalf of Exelixis pursuant to work under the Mode of Action Program; (b) [ * ].
Sample 1Sample 2
Quality Target means the PPM for Wire Harnesses determined as described below for the calendar year: FISCAL YEAR ENDING QUALITY TARGET ------------------ -------------- 1995 Current PPM Rate x [*] 1996 Current PPM Rate x [*] 1997 Current PPM Rate x [*] 1998 Current PPM Rate x [*] 1999 Current PPM Rate x [*] 2000 Current PPM Rate x [*] 2001 Current PPM Rate x [*] 2002 Current PPM Rate x [*] *Filed under an application for confidential treatment with the Securities and Exchange Commission. provided, however, that in no event shall the Quality Target be less than a PPM for Wire Harnesses of [*] for any calendar year.
Sample 1

Examples of Quality Target in a sentence

  • The main development studies performed were the characterisation of the reference product, Quality Target Product Profile (QTPP) of the drug product, excipient compatibility studies, prototype formulation and optimisation studies.

  • The Quality Target Product Profile (QTPP), potential CQAs of the drug product (as defined in ICH Q8) and previous experience from related products can help identify potential CQAs of the drug substance.

  • After the evaluation of the Frequency Quality Evaluation Criteria for a certain period, it may be determined that the values obtained are worse than the Frequency Quality Target Parameters or that of the Frequency Restoration Control Error Target Parameters.

  • As a result of these changes the index of the Sub-Fund will be changed from Russell 2000® Index (the “Existing Index”) to Russell 2000 0.4 Quality Target Exposure Factor Net Tax Index (the “New Index”).

  • The MAH has identified the Quality Target Product Profile and Critical Quality Attributes (CQA).

  • The main development studies performed were the characterisation of the reference product, Quality Target Product Profile (QTPP) of the drug product, prototype formulation and selection of the sterilisation method.

  • This data will be captured to facilitate future audit and review. Quality Indicator: refers to an outcome for which there is a sufficient evidence base to recommend a standard e.g. caecal intubation rate Key Quality Target: refers to the target associated with Quality Indicators Key Recommendation: refers to recommendations that should be implemented in each endoscopy unit to fully support quality improvement activities.

  • If Supplier fails to meet the Quality Target during such period, InFocus shall have the right (but not the obligation) to cancel the Agreement and outstanding Purchase Orders shall remain in place with Supplier providing targeted screening of Products (pipeline inventory and/or other sites as designated by InFocus) delivered to InFocus so that InFocus will have no liability for specific Products which do not meet the Quality Target.Epidemic and Catastrophic failures are as defined in Exhibit H.

  • However, in order to have a closer supervision of the Frequency Quality Evaluation Criteria the evaluation period is defined to be of one month whereas the Frequency Quality Target Parameters and Frequency Restoration Control Error Target Parameters are evaluated on a yearly basis.This section gives an overview on the Frequency Quality Evaluation Criteria which are defined by the NC LFCR and briefly explains the calculation of the criteria from available measurement data.

  • QbD requires a Target Product Profile; it may be called as Quality Target Product Profile (QTPP) which defines theQuality by design approach: Regulatory need 5 expectations in final product.

Related to Quality Target

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Yearly (1/Year) sampling frequency means the sampling shall be done in the month of September, unless specifically identified otherwise in the effluent limitations and monitoring requirements table.

  • Yearly (1/Year) sampling frequency means the sampling shall be done in the month of September, unless specifically identified otherwise in the effluent limitations and monitoring requirements table.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Drug sample means a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Finished Product means a cannabis product in its final form to be sold at a retail premises.

  • Product Category means the applicable category which best describes the product as listed in this Section 94508.

  • Clinical review criteria means the written screening procedures, decision abstracts, clinical protocols, and practice guidelines used by a health carrier to determine the necessity and appropriateness of health care services.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Product Specifications means the specifications, features and/or terms of any "Contract" (as defined in the LME Rules) listed for trading on the LME, as described in the LME Rules;

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Semi-annual (2/Year) sampling frequency means the sampling shall be done during the months of June and December, unless specifically identified otherwise.

  • Product Specification means a product specification for a Medical Device set out in Schedule 2;

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Semi-annual (2/Year) sampling frequency means the sampling shall be done during the months of June and December, unless specifically identified otherwise.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Manufacturing Site means the facilities where a Compound is Manufactured by or on behalf of a Party, as such Manufacturing Site may change from time to time in accordance with Section 8.7.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Contract Specific Goals means the subcontracting goals for MBE and WBE participation established for a particular contract.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.